Braunschweig, Germany

Stefan Hoffmann

This inventor holds 1 USPTO granted patent. Top assignee: Gesellschaft Fur Biotechnologische Forschung Mbh Igbf). Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Hoffmann

Introduction

Stefan Hoffmann is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly through his innovative work on peptide intermediates. His expertise and dedication to research have led to the development of valuable patents that advance scientific knowledge.

Latest Patents

Stefan Hoffmann holds a patent for peptide intermediates, which showcases his ability to create novel solutions in biotechnology. This patent is a testament to his innovative thinking and commitment to improving biotechnological processes. He has 1 patent to his name, reflecting his impactful contributions to the field.

Career Highlights

Hoffmann is currently employed at Gesellschaft für Biotechnologische Forschung mbH (IGBF), where he continues to push the boundaries of biotechnological research. His work at IGBF has allowed him to collaborate with other experts in the field and contribute to groundbreaking projects that have the potential to transform the industry.

Collaborations

One of his notable collaborators is Ronald Frank, with whom he has worked closely on various projects. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant advancements in biotechnology.

Conclusion

Stefan Hoffmann's contributions to the field of biotechnology through his patent on peptide intermediates highlight his role as an influential inventor. His work at Gesellschaft für Biotechnologische Forschung mbH and collaborations with fellow researchers further emphasize his commitment to advancing scientific knowledge.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…